B20-B24 A15-A19
Conditions
Interventions
Group 1: Semi-structured interviews will be conducted at in the first half and toward the end of the trial. We are aiming to include 15 healthcare providers, 3 decision makers and 15 patients or until
Sponsors
Universitätsklinikum Heidelberg Sektion Klinische Tropenmedizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adult aged = 18 years old Either: (1) Routine healthcare worker participating in either of the two prospective studys on FujilAM and Omega CD4 or (2) Patient or parent of patient tested or to be tested with FujiLAM or Omega CD4 as part of the study or (3) decision maker involved with implementation of novel tests.
Exclusion criteria
Exclusion criteria: adolescents and parents of patients aged < 18 years, Unable to provide consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To investigate user perspectives on FujiLAM (including perspectives of end- users (such as patients), but also professional users such as laboratory technicians, clinicians, nurses, and decision-makers for use as a diagnostic test in PLHIV 2. To investigate and compare experiences and challenges with diagnostic testing for TB in PLHIV using the different diagnostic approaches (FujiLAM, AlereLAM, Xpert, microscopy, culture) 3. To understand feasibility and preferences with regard to diagnosing TB in PLHIV and how FujiLAM changes these | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To investigate and compare experiences and challenges with diagnostic testing for TB in children using the different diagnostic approaches (FujiLAM, AlereLAM, Xpert, microscopy, culture) 2. To understand feasibility and preferences with regard to diagnosing TB in children and how FujiLAM changes these | — |
Countries
Malawi, Zambia
Contacts
Public ContactClaudia Denkinger
Universitätsklinikum Heidelberg Sektion Klinische Tropenmedizin
Outcome results
None listed